These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26901016)

  • 1. Radiographic Appearance of Transforaminal Lumbar Interbody Fusion Performed With and Without Recombinant Human Morphogenetic Protein-2.
    Stensby JD; Kaliney RW; Alford B; Shen FH; Patrie JT; Fox MG
    AJR Am J Roentgenol; 2016 Mar; 206(3):588-94. PubMed ID: 26901016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of recombinant human bone morphogenetic protein-2 in single-level posterior lumbar interbody arthrodesis.
    Michielsen J; Sys J; Rigaux A; Bertrand C
    J Bone Joint Surg Am; 2013 May; 95(10):873-80. PubMed ID: 23677353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity.
    Rahman RK; Buchowski JM; Stephens B; Dorward IG; Koester LA; Bridwell KH
    Spine (Phila Pa 1976); 2013 Dec; 38(26):2264-71. PubMed ID: 24108280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
    Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
    Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2).
    McClellan JW; Mulconrey DS; Forbes RJ; Fullmer N
    J Spinal Disord Tech; 2006 Oct; 19(7):483-6. PubMed ID: 17021411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD; Kim JY
    J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2.
    Pradhan BB; Bae HW; Dawson EG; Patel VV; Delamarter RB
    Spine (Phila Pa 1976); 2006 May; 31(10):E277-84. PubMed ID: 16648733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI of transforaminal lumbar interbody fusion: imaging appearance with and without the use of human recombinant bone morphogenetic protein-2 (rhBMP-2).
    Fox MG; Goldberg JM; Gaskin CM; Barr MS; Patrie JT; Shen FH; Alford B
    Skeletal Radiol; 2014 Sep; 43(9):1247-55. PubMed ID: 24913556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion.
    Nandyala SV; Marquez-Lara A; Fineberg SJ; Pelton M; Singh K
    Spine (Phila Pa 1976); 2014 Feb; 39(3):185-91. PubMed ID: 24253788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
    Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
    Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis.
    Roh JS; Yeung CA; Field JS; McClellan RT
    J Orthop Surg Res; 2013 Dec; 8():49. PubMed ID: 24373225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
    Villavicencio AT; Burneikiene S
    Spine J; 2016 Oct; 16(10):1208-1213. PubMed ID: 27343729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcome of graft resorption in anterior lumbar interbody fusion: using femoral ring allografts and recombinant human bone morphogenetic protein-2.
    Kayanja M; Orr RD
    Spine (Phila Pa 1976); 2014 Mar; 39(5):374-80. PubMed ID: 24299714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Bone Morphogenetic Protein in Spinal Transforaminal Lumbar Interbody Fusion: Our Experience.
    Colom-Beauchamp E; Beaton-Comulada D; Rodriguez JA; Pérez-López JC; Montañez-Huertas J; Escobar-Medina E; Massanet-Vollrath J
    P R Health Sci J; 2017 Sep; 36(3):173-178. PubMed ID: 28915307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft.
    Burkus JK; Sandhu HS; Gornet MF
    Spine (Phila Pa 1976); 2006 Apr; 31(7):775-81. PubMed ID: 16582851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforaminal lumbar interbody fusion with rhBMP-2 in spinal deformity, spondylolisthesis, and degenerative disease--part 1: Large series diagnosis related outcomes and complications with 2- to 9-year follow-up.
    Crandall DG; Revella J; Patterson J; Huish E; Chang M; McLemore R
    Spine (Phila Pa 1976); 2013 Jun; 38(13):1128-36. PubMed ID: 23370679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.
    Chen NF; Smith ZA; Stiner E; Armin S; Sheikh H; Khoo LT
    J Neurosurg Spine; 2010 Jan; 12(1):40-6. PubMed ID: 20043763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.